00533nas a2200169   4500000000100000000000100001008004100002100001400043700001400057700002100071700001400092700002100106245020600127300000900333490000700342022001400349       2015                            d1 aG. Baxter1 aC. Morgan1 aS. Jenkins-Jones1 aC. Currie1 aD. Schultewolter00aAssociation of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study  aA6580 v18  a1098-3015